Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9682641)

  • 1. Variation in the staging of colorectal carcinomas: a survey of current practice.
    Raraty MG; Winstanley JH
    Ann R Coll Surg Engl; 1998 May; 80(3):188-91. PubMed ID: 9682641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical trainees' understanding of Dukes' staging in rectal cancer.
    Rahman GA; Mungadi IA
    Niger J Med; 2009; 18(1):75-8. PubMed ID: 19485154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dukes' staging is poorly understood by doctors managing colorectal cancer.
    Mainprize KS; Mortensen NJ; Warren BF
    Ann R Coll Surg Engl; 2002 Jan; 84(1):23-5. PubMed ID: 11892729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variance of surgeons versus pathologists in staging of colorectal cancer.
    Jha MK; Corbett WA; Wilson RG; Koreli A; Papagrigoriadis S
    Minerva Chir; 2006 Oct; 61(5):385-91. PubMed ID: 17159746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
    Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
    Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different distribution of Dukes' stage between proximal and distal colorectal cancer.
    Ikeda Y; Akagi K; Kinoshita J; Abe T; Miyazaki M; Mori M; Sugimachi K
    Hepatogastroenterology; 2002; 49(48):1535-7. PubMed ID: 12397728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma.
    Purdie CA; Piris J
    Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Classification of colorectal cancers: current results from the catchment area of the Graz Institute of Pathology].
    Klimpfinger M; Hauser H; Beham A; Denk H
    Wien Med Wochenschr; 1988 Jun; 138(11-12):267-70. PubMed ID: 3176506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.
    Nozoe T; Honda M; Inutsuka S; Yasuda M; Korenaga D
    Oncol Rep; 2003; 10(1):39-43. PubMed ID: 12469142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to optimal assessment of lymph nodes in colorectal cancer specimens.
    Wright FC; Law CH; Last LD; Ritacco R; Kumar D; Hsieh E; Khalifa M; Smith AJ
    Am J Clin Pathol; 2004 May; 121(5):663-70. PubMed ID: 15151206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
    De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
    Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular staging for survival prediction of colorectal cancer patients.
    Eschrich S; Yang I; Bloom G; Kwong KY; Boulware D; Cantor A; Coppola D; Kruhøffer M; Aaltonen L; Orntoft TF; Quackenbush J; Yeatman TJ
    J Clin Oncol; 2005 May; 23(15):3526-35. PubMed ID: 15908663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
    Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
    World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
    Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
    Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymph node micrometastases and expression of metastasis-related gene proteins in patients with colorectal cancer].
    Fan YZ; Li XP; Liu WF; Li GM
    Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):181-5. PubMed ID: 16635348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surgeon's decision as a prognostic factor in a pool of patients with colorectal cancer coming from different institutions.
    Franchi F; Rossi L; Izzo L; Binda B; Pastore C; Falconi C; Amoroso A; Cammarata A; Cicconetti F; Seminara P
    J Exp Clin Cancer Res; 2003 Sep; 22(3):385-8. PubMed ID: 14582695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.